NCCN Guidelines Insights: Bone Cancer, Version 2.2017

J Natl Compr Canc Netw. 2017 Feb;15(2):155-167. doi: 10.6004/jnccn.2017.0017.

Abstract

The NCCN Guidelines for Bone Cancer provide interdisciplinary recommendations for treating chordoma, chondrosarcoma, giant cell tumor of bone, Ewing sarcoma, and osteosarcoma. These NCCN Guidelines Insights summarize the NCCN Bone Cancer Panel's guideline recommendations for treating Ewing sarcoma. The data underlying these treatment recommendations are also discussed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amputation, Surgical
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biopsy
  • Bone Neoplasms / epidemiology
  • Bone Neoplasms / pathology
  • Bone Neoplasms / therapy*
  • Chemoradiotherapy, Adjuvant / standards
  • Chemotherapy, Adjuvant / standards
  • Clinical Trials as Topic
  • Drug Resistance, Neoplasm
  • Humans
  • Incidence
  • Magnetic Resonance Imaging
  • Medical Oncology / standards
  • Neoplasm Recurrence, Local / diagnosis
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / therapy*
  • Neoplasm Staging
  • Positron Emission Tomography Computed Tomography
  • Practice Guidelines as Topic
  • Prognosis
  • Sarcoma, Ewing / epidemiology
  • Sarcoma, Ewing / pathology
  • Sarcoma, Ewing / therapy*
  • Survival Rate

Substances

  • Antineoplastic Agents